Skip to main content
. Author manuscript; available in PMC: 2015 Jun 3.
Published in final edited form as: J Am Coll Cardiol. 2014 Apr 2;63(21):2261–2269. doi: 10.1016/j.jacc.2014.02.588

Figure 3. The effect of clinical characteristics on the WBC expression of SCN5A VC and VD.

Figure 3

Panels A, C, E, G, I, and K as well as B, D, F, H, J, and L compare the effects of race, sex, origin of the cardiomyopathy, left ventricular ejection fraction (LVEF), New York Heart Association heart failure stage (NYHA), and QRS duration on WBC variant VC and VD levels, respectively.